Becton Dickinson Income After Taxes 2010-2024 | BDX
Becton Dickinson annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Becton Dickinson income after taxes for the quarter ending June 30, 2024 was $0.487B, a 19.66% increase year-over-year.
- Becton Dickinson income after taxes for the twelve months ending June 30, 2024 was $1.459B, a 12.32% decline year-over-year.
- Becton Dickinson annual income after taxes for 2023 was $1.53B, a 6.42% decline from 2022.
- Becton Dickinson annual income after taxes for 2022 was $1.635B, a 1.93% increase from 2021.
- Becton Dickinson annual income after taxes for 2021 was $1.604B, a 355.68% increase from 2020.
Becton Dickinson Annual Income After Taxes
(Millions of US $) |
| 2023 |
$1,530 |
| 2022 |
$1,635 |
| 2021 |
$1,604 |
| 2020 |
$352 |
| 2019 |
$1,233 |
| 2018 |
$311 |
| 2017 |
$1,100 |
| 2016 |
$977 |
| 2015 |
$695 |
| 2014 |
$1,185 |
| 2013 |
$929 |
| 2012 |
$1,109 |
| 2011 |
$1,201 |
| 2010 |
$1,115 |
| 2009 |
$1,167 |
Becton Dickinson Quarterly Income After Taxes
(Millions of US $) |
| 2024-06-30 |
$487 |
| 2024-03-31 |
$537 |
| 2023-12-31 |
$282 |
| 2023-09-30 |
$153 |
| 2023-06-30 |
$407 |
| 2023-03-31 |
$461 |
| 2022-12-31 |
$509 |
| 2022-09-30 |
$287 |
| 2022-06-30 |
$390 |
| 2022-03-31 |
$390 |
| 2021-12-31 |
$568 |
| 2021-09-30 |
$-104 |
| 2021-06-30 |
$406 |
| 2021-03-31 |
$299 |
| 2020-12-31 |
$1,003 |
| 2020-09-30 |
$-394 |
| 2020-06-30 |
$286 |
| 2020-03-31 |
$183 |
| 2019-12-31 |
$277 |
| 2019-09-30 |
$163 |
| 2019-06-30 |
$451 |
| 2019-03-31 |
$20 |
| 2018-12-31 |
$599 |
| 2018-09-30 |
$-135 |
| 2018-06-30 |
$594 |
| 2018-03-31 |
$-12 |
| 2017-12-31 |
$-136 |
| 2017-09-30 |
$328 |
| 2017-06-30 |
$-133 |
| 2017-03-31 |
$344 |
| 2016-12-31 |
$561 |
| 2016-09-30 |
$20 |
| 2016-06-30 |
$390 |
| 2016-03-31 |
$338 |
| 2015-12-31 |
$229 |
| 2015-09-30 |
$182 |
| 2015-06-30 |
$62 |
| 2015-03-31 |
$216 |
| 2014-12-31 |
$235 |
| 2014-09-30 |
$301 |
| 2014-06-30 |
$326 |
| 2014-03-31 |
$287 |
| 2013-12-31 |
$271 |
| 2013-09-30 |
$90 |
| 2013-06-30 |
$292 |
| 2013-03-31 |
$276 |
| 2012-12-31 |
$271 |
| 2012-09-30 |
$274 |
| 2012-06-30 |
$312 |
| 2012-03-31 |
$275 |
| 2011-12-31 |
$249 |
| 2011-09-30 |
$254 |
| 2011-06-30 |
$322 |
| 2011-03-31 |
$311 |
| 2010-12-31 |
$314 |
| 2010-09-30 |
$232 |
| 2010-06-30 |
$294 |
| 2010-03-31 |
$285 |
| 2009-12-31 |
$304 |
| 2009-09-30 |
$260 |
| 2009-06-30 |
$339 |
| 2009-03-31 |
$259 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$67.812B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
